MedTrace Logo

Effect of Prolotherapy in Knee Osteoarthritis.

NCT04178304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2023-04-05

No results posted yet for this study

Summary

Patients with primary knee osteoarthritis will be included in the study, plain X-ray for the affected knee, followed by musculoskeletal ultrasound assessment will be done. The intervention: intra-articular injection and extra-articular injections of 25% dextrose. Follow up will be done at 24 weeks after the last injection both clinically and ultrasonographically .

Aim: Determine whether prolotherapy improves pain. stiffness and function of symptomatic knee osteoarthritis and determine ultrasonographic changes before and after prolotherapy.

Conditions

Interventions

DRUG

Prolotherapy with 25% Dextrose

Intra-articular injection of 6mL of 25% dextrose Extra-articular injection at tender sites with 25% dextrose

Sponsors & Collaborators

  • University of Alexandria

    lead OTHER

Principal Investigators

  • Yousra H Abdel-Fattah, MD · Alexandria University Faculty of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-15
Primary Completion
2021-10-30
Completion
2021-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04178304 on ClinicalTrials.gov